Edesa Biotech Média de recomendação
Qual é o Média de recomendação de Edesa Biotech?
O Média de recomendação de Edesa Biotech, Inc. é 2.00
Qual é a definição de Média de recomendação?
A média da recomendação é a média das classificações dos analistas das ações, variando de 1,0 (compra forte) a 5,0 (venda forte).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Média de recomendação de empresas na Setor Health Care em NASDAQ em comparação com Edesa Biotech
O que Edesa Biotech faz?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Empresas com média de recomendação semelhantes a Edesa Biotech
- Cabot Oil & Gas tem Média de recomendação de 1.96
- Truist tem Média de recomendação de 1.96
- Delta Air Lines tem Média de recomendação de 1.96
- Discover Services tem Média de recomendação de 1.96
- United Micro Electronics tem Média de recomendação de 1.96
- Tapestry Inc tem Média de recomendação de 1.97
- Edesa Biotech tem Média de recomendação de 2.00
- Trip.com Ltd tem Média de recomendação de 2.03
- Sherwin-Williams Co tem Média de recomendação de 2.03
- Canadian Pacific Kansas City tem Média de recomendação de 2.03
- Arista Networks Inc tem Média de recomendação de 2.03
- Anheuser-Busch InBev SA/NV tem Média de recomendação de 2.03
- Celanese Corp tem Média de recomendação de 2.04